+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
Global Cardiovascular Clinical Trials Market Report 2024 - Product Thumbnail Image

Global Cardiovascular Clinical Trials Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 413 Pages
  • Global
From
From
Cardiovascular Therapeutics Market 2024-2028 - Product Thumbnail Image

Cardiovascular Therapeutics Market 2024-2028

  • Report
  • March 2024
  • 183 Pages
  • Global
From
From
Cardiovascular Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 300 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more